Patents by Inventor Nicholas Robert Pope

Nicholas Robert Pope has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising methylphenidate and another drug
    Patent number: 7267949
    Abstract: A process of treating a subject that is undergoing methylphenidate therapy and concomitant therapy with another drug undergoes or interferes with P450 metabolism, wherein the methylphenidate is d-threo-methylphenidate.
    Type: Grant
    Filed: October 21, 2002
    Date of Patent: September 11, 2007
    Assignee: Celltech Pharma Europe Limited
    Inventors: Andrew John McGlashan Richards, Nicholas Robert Pope
  • Composition comprising methylphenidate and another drug
    Publication number: 20030049205
    Abstract: A process of treating a subject that is undergoing methylphenidate therapy and concomitant therapy with another drug undergoes or interferes with P450 metabolism, wherein the methylphenidate is d-threo-methylphenidate.
    Type: Application
    Filed: October 21, 2002
    Publication date: March 13, 2003
    Inventors: Andrew John McGlashan Richards, Nicholas Robert Pope
  • Composition comprising methylphenidate and another drug
    Patent number: 6468504
    Abstract: A process of treating a subject that is undergoing methylphenidate therapy and concomitant therapy with another drug undergoes or interferes with P450 metabolism, wherein the methylphenidate is d-threo-methylphenidate.
    Type: Grant
    Filed: June 19, 2000
    Date of Patent: October 22, 2002
    Assignee: Medeva Europe, Ltd.
    Inventors: Andrew John McGlashan Richards, Nicholas Robert Pope
  • Composition comprising methylphenidate and another drug
    Patent number: 6113879
    Abstract: A method of treating a subject that is undergoing methylphenidate therapy and concomitant therapy with another drug undergoes or interferes with P.sub.450 metabolism, wherein the methylphenidate is d-threo-methylphenidate.
    Type: Grant
    Filed: June 29, 1998
    Date of Patent: September 5, 2000
    Assignee: Medeva Europe Limited
    Inventors: Andrew John McGlashan Richards, Nicholas Robert Pope
  • Composition comprising methylphenidate and another drug
    Patent number: 5773478
    Abstract: A method of treating a subject that is undergoing methylphenidate therapy and concomitant therapy with another drug undergoes or interferes with P.sub.450 metabolism, wherein the methylphenidate is d-threo-methylphenidate.
    Type: Grant
    Filed: July 15, 1996
    Date of Patent: June 30, 1998
    Assignee: Medeva Europe Limited
    Inventors: Andrew John McGlashan Richards, Nicholas Robert Pope